Skip to content

Total debt at other companies

Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$4.32B-1.7%
Neogen logo
NeogenNEOG
$793.3M-11.2%
Balchem logo
BalchemBCPC
$37.36M-1.7%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$13.53M+56.4%
Merck & Co. logo
Merck & Co.MRK
Zoetis logo
ZoetisZTS

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.27B+31.4%
Enterprise value$1.25B+33.9%
P/E13.4×-17.1×
P/S0.9×0.0×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Calculated from Phibro Animal Health’s reported figures.

Plus components not separately reported this period.

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phibro Animal Health's total debt?
Phibro Animal Health (PAHC) reported total debt of $32.25M in Q1 2026.
How has Phibro Animal Health's total debt changed year-over-year?
Phibro Animal Health's total debt increased by 27.8% year-over-year, from $25.24M to $32.25M.
What is the long-term trend for Phibro Animal Health's total debt?
Over 4 years (2021 to 2025), Phibro Animal Health's total debt has grown at a 7.7% compound annual growth rate (CAGR), from $44M to $59.12M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.